Tixagevimab-Cilgavimab Treatment and Cardiovascular Events: Immortal Time Bias

被引：1
|
作者：
Montastruc, Francois [1 ,2 ,3 ]
de Canecaude, Claire [1 ,2 ]
机构：
[1] Toulouse Univ Hosp CHU, Fac Med, Ctr PharmacoVigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, Toulouse, France
[2] Toulouse Univ Hosp, Ctr Invest Clin 1436, Team PEPSS Pharmacol Populat cohorteS & biobanqueS, Toulouse, France
[3] Toulouse Univ Hosp, Fac Med, Ctr PharmacoVigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, 37 Allees Jules Guesde, F-31000 Toulouse, France
来源：
CLINICAL INFECTIOUS DISEASES | 2023年 / 76卷 / 11期
关键词：
D O I：
10.1093/cid/ciad089
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2044 / 2045
页数：2
相关论文
共 50 条
  • [31] Tixagevimab-Cilgavimab Decreases the Rate of SARS-CoV-2 Infection Among Solid Organ Transplant Recipients
    Sanayei, Ava M.
    Montalvan, Adriana
    Faria, Isabella
    Ochalla, Julia
    Pavlakis, Martha
    Blair, Barbra M.
    Alonso, Carolyn D.
    Curry, Michael
    Saberi, Behnam
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (08) : 1784 - 1792
  • [32] Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis
    Duminuco, Andrea
    Nardo, Antonella
    Orofino, Alessandra
    Giunta, Giuliana
    Conticello, Concetta
    Del Fabro, Vittorio
    Figuera, Amalia
    Chiarenza, Annalisa
    Milone, Giuseppe
    Leotta, Salvatore
    Cupri, Alessandra
    Parisi, Marina
    Mauro, Elisa
    Vetro, Calogero
    Di Raimondo, Francesco
    Romano, Alessandra
    Palumbo, Giuseppe A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S446 - S447
  • [33] COVID-19 outcomes in solid organ transplant patients given tixagevimab-cilgavimab prophylaxis and/or bebtelovimab treatment in a nurse-led program
    Cochran, W.
    Alejandre, S. Salto
    Barker, L.
    Freed, K.
    Carter, D.
    Bannon, J.
    Goddard, D.
    Werbel, W.
    Mostafa, H.
    Brennan, D.
    Shah, P.
    Avery, R.
    SWISS MEDICAL WEEKLY, 2022, 152 : 31S - 31S
  • [34] SARS-COV-2 Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab in Haematological, Immunocompromised Patients in the Omicron Era
    Hoechstetter, Manuela A.
    Hollwich, Eva-Maria
    Illner, Doris
    Pham, Thu-Trang
    von Bergwelt-Baildon, Michael
    Dreyling, Martin
    Wendtner, Clemens-Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 690 - 699
  • [35] Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review
    Ustianowski, Andrew
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (12) : 1517 - 1527
  • [36] | Immortal time bias
    Ranstam, Jonas
    Cook, Jonathan A.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (07) : 642 - 642
  • [37] Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Stuver, Robert
    Shah, Gunjan L.
    Korde, Neha S.
    Roeker, Lindsey E.
    Mato, Anthony R.
    Batlevi, Connie L.
    Chung, David J.
    Doddi, Sital
    Falchi, Lorenzo
    Gyurkocza, Boglarka
    Hamilton, Audrey
    Lin, Ya-Hui
    Jakubowski, Ann A.
    Joffe, Erel
    Landau, Heather L.
    Lin, Richard J.
    Mailankody, Sham
    Palomba, M. Lia
    Park, Jae H.
    Perales, Miguel-Angel
    Ponce, Doris M.
    V. Ramanathan, Lakshmi
    Salles, Gilles A.
    Scordo, Michael
    Seo, Susan K.
    Shah, Urvi A.
    Stein, Eytan M.
    Straus, David
    Usmani, Saad Z.
    Young, James W.
    Zelenetz, Andrew D.
    Noy, Ariela
    Vardhana, Santosha A.
    CANCER CELL, 2022, 40 (06) : 590 - 591
  • [38] Immortal time bias
    Obel, Niels
    AIDS, 2015, 29 (07) : 859 - 860
  • [39] A model program for pharmacist-managed healthcare delivery: A tixagevimab-cilgavimab (EVUSHELD) clinic at a Veterans Affairs healthcare system
    Buehrle, Deanna J.
    Shields, Jenna
    Lopez, Marcos
    Mascara, Gerard P.
    Coppler, Tami
    Mobayed, Leeanne
    Clancy, Cornelius J.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024, 7 (01): : 31 - 38
  • [40] SARS-CoV-2 Vaccination Rates and Uptake of Tixagevimab-Cilgavimab Among a Cohort of Pediatric Solid Organ Transplant Recipients
    Reis, C.
    Madigan, T.
    Ristagno, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S390 - S390
12345